title: Drug eluting stents: maximising benefit and minimising cost.
abstract: A policy of selective implantation of drug eluting stents, in a minority of lesions most likely to benefit, seems to be a rational way to employ this new and currently costly technology.
authors.affiliation: Cardiovascular Research Group, Division of Clinical Sciences (Northern General Hospital), University of Sheffield, Sheffield, UK.J.Gunn@Sheffield.ac.uk
authors.forename: J
authors.initials: J
authors.lastname: Gunn
authors.forename: A C
authors.initials: AC
authors.lastname: Morton
authors.forename: C
authors.initials: C
authors.lastname: Wales
authors.forename: C M H
authors.initials: CM
authors.lastname: Newman
authors.forename: D C
authors.initials: DC
authors.lastname: Crossman
authors.forename: D C
authors.initials: DC
authors.lastname: Cumberland
mesh_terms: D023903:Coronary Restenosis / Q000191:economics / Q000517:prevention & control*; D017046:Cost Savings; D003365:Costs and Cost Analysis; D003657:Decision Making; D004343:Drug Implants / Q000009:adverse effects / Q000191:economics; D004867:Equipment Design; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D015607:Stents / Q000009:adverse effects / Q000191:economics
chemical_list: D004343:Drug Implants